HLA class II specificities in vasculitis with antibodies to neutrophil cytoplasmic antigens  by Spencer, Stephen J.W. et al.
Kidney International, Vol. 41(1992), pp. 105 9—1063
HLA class II specificities in vasculitis with antibodies to
neutrophil cytoplasmic antigens
STEPHEN J.W. SPENCER, AINE BURNS, GILLIAN GASKIN, CHARLES D. PUSEY,
and ANDREW J. REES
Renal Unit, Department of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London, England, United Kingdom
HLA class II specificities in vasculitis with antibodies to neutrophil
cytoplasmic antigens. HLA class II genes were examined in patients
with small vessel vasculitis associated with anti-neutrophil cytoplasmic
antibodies (ANCA) using restriction fragment length polymorphism and
allele specific oligonucleotide typing. Fifty-nine patients were studied,
34 with Wegener's granulomatosis and 25 with microscopic polyarten-
tis, and their results were compared with those from 1103 British
Caucasoid controls. The frequency of HLA-DQw7 was significantly
increased in patients with vasculitis (patients 53%; controls 27.8%, x2
17.8, Pc < 0.0025, relative risk 2.9), and all the DQw7 bearing
haplotypes commonly found in Caucasoid populations contributed to
the increase. By contrast, the frequency of HLA-DR3 bearing haplo-
types was decreased in the patients (patients 6.8%; controls 21.6%, x2
6.7, P < 0.01). HLA specificities were similar in the groups of patients
presenting with Wegener's granulomatosis and microscopic polyarteri-
tis and with different types of ANCA assessed by indirect immunoflu-
orescence. However, patients with the DQw7, DR4 haplotype were
significantly more likely to have transiently positive tests for ANCA
than patients with other DQw7 bearing haplotypes, whereas patients
with DR2 bearing haplotypes were more likely to have persistently
positive ANCA. These results show that HLA class II genes are
associated with small vessel vasculitis and may influence the duration of
the associated autoimmune response.
Wegener's granulomatosis (WG) and microscopic polyarteri-
tis (MP) are diseases which are associated with antibodies to
neutrophil cytoplasmic antigens (ANCA) and characterized by
widespread inflammation and necrosis of arterioles, venules,
and to a lesser extent small arteries. Both diseases were defined
originally in autopsy studies [1, 2] and were distinguished by the
presence or absence of granulomas. Nowadays the diagnoses
are usually made using clinical criteria [3—5]. However, it is not
clear whether these conditions are separate entities, or merely
different expressions of the same disease, analogous to the
tuberculoid and lepromatous forms of leprosy. Certainly, the
two cannot always be distinguished accurately on clinical
grounds, especially since the introduction of treatment capable
of inducing a remission. Even so, the severity and extent of
inflammation varies considerably from patient to patient, as
does the tendency for the disease to persist [6].
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The pathogenesis of these disorders has yet to be elucidated,
but the recent description of autoantibodies to neutrophil cyto-
plasmic antigens (ANCA) [7, 8] and to endothelial cells [9—il]
suggests an autoimmune basis. Two types of ANCA can be
distinguished by indirect immunofluorescence: cytoplasmic or
c-ANCA, and perinuclear or p-ANCA. Cytoplasmic ANCA are
detected in almost all patients with active WG and some with
MP. They usually react with a 29 kd serine proteinase found in
the primary granules of neutrophils [12—14], recently identified
as proteinase-3 [15, 16]. Perinuclear ANCA are found in pa-
tients with MP and isolated rapidly progressive glomerulone-
phritis (RPGN), and are usually directed against myeloperox-
idase [17].
Susceptibility to autoimmune disease is strongly influenced
by genes within the HLA complex on the short arm of chromo-
some 6. The HLA complex consists of at least three sets of
genes: class I genes encoding HLA-A, -B and -C molecules;
class II genes encoding HLA-DP, -DQ and -DR molecules; and
class III genes encoding a variety of molecules including
complement components, tumor necrosis factor, and represen-
tatives of the HSP7O family of heat shock proteins [18—20].
HLA class II molecules are expressed on the surface of antigen
presenting cells where they facilitate the interaction between
antigenic peptide and T cell receptors. They are heterodimer
glycoproteins consisting of a and f3 chains encoded by A and B
genes, respectively. Most class II genes are highly polymorphic
and this accounts for the numerous described HLA-class II
specificities, and for functional differences between their prod-
ucts [21].
HLA-DR and -DQ genes are in strong linkage disequilibrium,
which means that particular alleles are inherited together more
often than would be expected by chance. This has complicated
the serological analysis of the HLA complex because of the
difficulty of raising suitably specific antisera. Molecular biolog-
ical techniques have been more informative and have recently
been used to identify individual DR and DQ alleles, and to show
that they are associated with particular autoimmune diseases
[22—26].
Serological techniques have been used to examine the HLA
specificities of a small number of patients with small vessel
vasculitis and isolated RPGN [27, 28]. Unfortunately, the
results were not decisive, at least in part because the techniques
used were not sufficiently precise. The purpose of the present
study was to examine the HLA-DR and -DQ gene frequencies
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in a large group of well defined patients with ANCA associated
vasculitis, and so to ascertain whether particular HLA-DR and
-DQ genes predispose to these disorders, and to determine
whether these genes correlate with clinical or serological as-
pects of the disease.
Methods
Patients
The HLA specificities of 59 patients (32 male, 27 female)
were ascertained between 1989 and 1990. They had all been
referred to the Renal Unit at the Hammersmith Hospital be-
tween 1975 and June 1990 for treatment of vasculitis with
evidence of systemic disease. Fifty-seven were referred in the
acute stage for control of severe disease and two referred later
for follow-up. Diagnoses were made using standard criteria
[4—61; 34 were diagnosed as having WG and 25 as MP (3 of these
had idiopathic RPGN, believed to represent MP confined to the
kidney). All but 8 had rapidly progressive glomerulonephritis.
Anti-neutrophil cytoplasmic antibodies were assayed by indi-
rect immunofluorescence, using the standard technique from
the First International ANCA Workshop [29]. They were de-
tected in all patients with active disease. Cytoplasmic ANCA
were found in 32 of 34 patients with WG, while tests for ANCA
were negative in the two remaining patients who were first
assayed after intensive immunosuppressive treatment. Fifteen
of 25 patients with MP also had c-AN CA, whilst the remaining
10 had p-ANCA. They comprize 38% of our patients with
Wegener' s granulomatosis and microscopic polyarteritis seen
during this period; 42 being referred before the study was
started in 1989 and 17 afterwards. The patients were treated
with a standard immunosuppressive regimen [2, 3]. Forty-nine
of these patients under long-term follow-up were studied to
examine the effect of HLA specificities on persistence of the
ANCA response. Forty-one of these formed part of a long-term
clinical and serological study of ANCA associated vasculitis
16]. The remaining eight patients presented later and fulfilled the
entry criteria for that study.
Restriction fragment length polymorphism
The HLA-DR and -DQ specificities were ascertained by
restriction fragment length polymorphisms (RFLP) using
Southern analysis, as described by Bidwell [30]. Genomic DNA
from peripheral blood leucocytes was digested with Taql en-
donuclease (NBL, Northumbria), and electrophoresed in agar
before transfer to nylon membranes (Hybond-N, Amersham).
The membranes were hybridized sequentially with 32P[s]-dCTP
radiolabelled c-DNA probes to HLA-DRB, -DQB and -DQA
genes. The probes used were: (i) a 520bp Pstl fragment of the
DRB1 gene from a DR4 individual; (ii) a 940bp EcoRl fragment
of the DQBI gene of a DR4, DQw7 individual; and (iii) a 1.3Kb
EcoRl fragment of the DQA1 gene from a DR4, DQAw3
individual. Unequivocal DR and DQ specificities can be as-
signed using this technique except when attempting to distin-
guish between DQw7 and DQw8, which cannot always be done
with confidence.
Allele specific oligonucleotide (ASO) probing
A previously described method 131] of ASO probing was used
to confirm that HLA-DQw7 and -DQw8 alleles had been assigned
correctly. Genomic DNA was amplified by the polymerase chain
reaction (PCR) using primers designed specifically to flank DNA
encoding the polymorphic DQJ31 domains. The primers were:
forward 5'-ATCGAATFCCAGAGGA1TrCGTGTAC-3'; re-
verse 5'-AACGTCGCCGCCCACTGACGTCGAT-3'. Thirty cy-
cles were performed; annealing was conducted at 45°C for two
minutes, denaturation at 94°C for two minutes, and extension at
72°C for two minutes. Amplified DNA was electrophoresed in 1%
agarose gels and transferred to Hybond filters, before hybridiza-
tion with a radiolabelled oligonucleotide probe specific for the
DQw7 allele [321. The filters were washed to a stringency of
2xSSC (1XSSC = 0.15 M NaCI, 0.015 M Na citrate) 0.1% SDS
(sodium dodecyl sulphate) at 58°C and exposed to Kodak XAR5
film at °70C. Hybridization indicated the presence of DQw7. We
have previously validated this method by nucleotide sequencing of
the amplified DNA [31].
Quantitation and statistics
The results from patients were compared with those of 1103
normal British Caucasoids typed by Bidwell using the same
methods. The significance of difference was assessed from 2 x 2
tables by Chi square. A correction for the number of compari-
Sons was made by multiplying the P values obtained by 24,
which is the number of different putative haplotypes that were
found in the Caucasoid control samples. Relative risk (RR) was
calculated using a standard formula [33, 34].
Results
Allogenotyping
Analysis of the RFLP generated by Taql digestion of ge-
nomic DNA hybridized with DRB and DQ probes, together
with ASO probing for DQw7, allowed the DRB, DQA and DQB
alleles to be identified in all 59 patients (Table 1). The expressed
DR and DQ molecules were inferred, and in every case these
were consistent with the inheritance of HLA class II haplotypes
that have previously been described in Caucasoids.
There was a statistically significant increase in the frequency
of DQw7 at the DQB locus. It was found in just over 53% of
patients compared to 27.8% of controls ( = 17.8, P < 0.0001,
Pc < 0.0025, RR 2.9). Both DR4 and DR5 are in linkage
disequilibrium with DQw7 and so putative haplotypes can be
assigned; these are shown in Table 2. The DQw7, DR4 haplo-
type was present in 31% of patients and 12% of controls, the
DQw7, DR5 haplotype in 17% of patients and 13% of controls,
and the DQw7, DR6 haplotype in 6.9% of patients and 2.0% of
controls. Thus, inheritance of DQw7 itself is important but the
effect may be influenced by the haplotype on which it is carried.
The frequency of DQw7 was similar in patients studied retro-
spectively (22 of 41; 54%) and those studied prospectively (9 of
17; 53%). The frequency was also increased in patients with
(52%) and without severe renal disease (63%).
By contrast, the putative DR3, DQw2a haplotype was appre-
ciably less common in the patients than in controls, It was
found in 6.8% of 59 patients compared to 21.8% of controls (,
= 6.7, P < 0.01). DQw2a is invariably inherited with DR3 in
Caucasoids, and so it was impossible to distinguish the effects
of these specificities separately.
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Table 1. The frequencies of the alleles of the HLA-class II
specificities in patients and controls
Alleles
Patients
N %
Con
N
trols
% P
DRB 59 100 1103 100
1 10 16.9 228 20.7 0.275 0.6
2 20 33.9 345 31.2 0.078 0.8
3 4 6.8 240 21.8 6.7 0.01
4 28 47.5 407 36.9 2.2 0.1
5 10 16.9 142 12.7 0.49 0.5
6 15 25.4 282 25.3 0.017 0.9
7 13 22 264 24.1 0.081 0.8
8 2 3.4 59 5.4 0.12 0.7
9 0 0 24 2.1 0.49 0.5
10 2 3.4 16.5 1.4 0.40 0.5
DQB 58 100
DQw2b 17 29
DQwS 24 41
1103
330
307
100
38
27.9
1.17
4.3
0.3
0.04
DQw6 17 29 474 43.3 3.6 0.05
DQw7 31 53 297 27.8 17.8 0.0001
DQw8 16 27.6 330 38 0.053 0.8
DQA 49 100 1103 100
Ia 12 24.4 307 27.9 0.122 0.7
lb 20 40.8 477 43.3 0.8 0.4
Ic 2 4 124 11.3 3.0 0.12
2 19 38.7 403 36.6 0.05 0.93
3 32 65.3 698 63.3 0.07 0.8
The DQB specificity w7 remains significantly increased in the pa-
tients after correction for the number of comparisons made (Pc < 0.01).
Clinical diagnosis and ANCA specificity
Sixteen of 34 (47%) patients with WG inherited DQw7, as did
15 of 24(62%) patients with MP. Similarly, DQw7 was found in
24 of 47 (5 1%) patients with c-ANCA, and 5 of 10(50%) of those
with p-ANCA. Only 2 (6%) patients with WG and 2 (8%) with
MP inherited the DR3, DQw2a haplotype. Thus, the overall
association with ANCA associated vasculitis could not be
explained by a stronger association with a particular type of
vasculitis, whether judged by clinical diagnosis or ANCA
specificity.
Persistence of detectable ANCA
Forty-nine patients were used to determine the effects of
HLA alleles on persistence of the autoimmune response. The
criteria used to segregate them into three groups are described
in detail by Gaskin et a! [61. This depended on the results of
serial ANCA assays after completion of induction immunosup-
pressive therapy. All these patients were treated using identical
protocols and no changes of therapy were made because of the
ANCA results.
Assays were persistently positive in 16 patients, intermit-
tently positive in 24 patients, and repeatedly negative in 9
patients. The frequency of DQw7 was identical in the three
groups (50% in each case), but the haplotype on which it was
inherited may not be. Patients who inherited the DR4, DQw7
haplotype were significantly less likely to have persistently
detectable ANCA (1 of 11 patients) than the patients who
inherited DQw7 on DR5 or DR6 bearing haplotypes (6 of 11, P
< 0.02 Fishers exact test). The HLA-DR2 bearing haplotypes
were significantly less common in patients with persistently
negative ANCA assays, irrespective of other HLA alleles
Table 2. The frequency of the common DQw7-bearing haplotypes in
the patients
Haplotype
Pati
N = 58
ents
%
Controls
N = 1103 % P
DR4DQw7 18 31 149 13.0 14.2 0.0004
DR5DQw7 10 17 142 12 0.9 0.45
DR6DQw7 4 6.9 23 2.0 5.6 0.05
which had been inherited. It was found in 9 of 16 who were
persistently positive patients, 7 of 24 intermittently positive and
one of 9 persistently negative (x2 = 8.5, P < 0.01). Thus, it
appears likely that DR4 is associated with transient and DR2
with persistent ANCA synthesis.
Discussion
This study provides evidence that HLA specificities are
associated both with susceptibility to ANCA associated vascu-
litis, and the duration of the accompanying autoantibody re-
sponse to neutrophil cytoplasmic antigens. Specifically, the
frequency of FILA-DQw7 was appreciably greater among pa-
tients with Wegener's granulomatosis and microscopic poly-
arteritis compared with controls, irrespective of the type of
ANCA present. The HLA-DQw7 specificity was inherited on a
variety of haplotypes in these patients, including DR4, DQw7,
DR5, DQw7 and DR6, DQw7. This maps the associated sus-
ceptibility gene for vasculitis to the DQBI locus, as the DQA
alleles which encode the DQa chain of the DQw7 molecule are
different on DR4 and DR5 bearing haplotypes. It also suggests
that the gene responsible is either the DQw7 allele itself or a
gene in linkage disequilibrium with it and located closer to the
centromere. This excludes genes encoding DR molecules as
well as the HLA class III genes, encoding complement compo-
nents and TNF, because these are closer to the telomere.
However, it does not exclude the recently described genes for
putative peptide transporters [35], which are located just cen-
tromeric to the DQB locus.
The HLA-DR3, DQw2 haplotype was much less frequent in
patients with ANCA associated vasculitis than controls, but the
difference did not reach statistical significance after rigorous
statistical corrections for the number of comparisons. Never-
theless, the idea that DR3 is protective is supported by two
further observations: first, Muller et al [28] found DR3 in only 2
of 24(8.3%) patients with isolated RPGN, a condition known to
be closely associated with ANCA and believed to be a "forme
fruste" of MP; and second, DR3 was absent in all nine patients
we have studied with systemic vasculitis due to the Churg-
Strauss syndrome (Spencer, Burns, Pusey and Rees, unpub-
lished data). If real, the protective effect of DR3 would be
inherited in dominant fashion, and there has been considerable
discussion about how dominant immune unresponsiveness
might occur. This is partly because certain DQB alleles appear
to confer dominant resistance to diabetes mellitus [22, 23], and
partly because of reports by Sasazuki and colleagues that
particular HLA alleles are associated with dominant unrespon-
siveness to a variety of exogenous antigens [361. Possible
explanations include allele-specific HLA dependent elimination
of autoreactive T cells in the thymus during ontogeny [37], and
allele specific induction of antigen-specific T suppressor cells
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peripherally [38], but presently there are no data on the relative
importance of either mechanism in humans.
The HLA specificities also appeared to influence the duration
of the ANCA response. The DR4, DQw7 haplotypes were
commonly associated with transient ANCA synthesis, whereas
DR2 bearing haplotypes were significantly more common in
patients with prolonged ANCA synthesis. These suggestions
are based on the study of a relatively small number of patients
and will need to be confirmed, but it is interesting that in healthy
individuals inheritance of HLA-DR4 bearing haplotypes is
associated with unusually high TNFa synthesis 138], while DR2
positive individuals have especially low TNFa synthesis [38,
391. Thus, patients with transient ANCA in this study inherited
HLA haplotypes associated with high TNF synthesis, and those
with persistent ANCA inherited those with low TNF synthesis.
This is analogous to the situation in systemic lupus erythema-
tosus, in which the haplotypes that determine TNF synthesis
are associated with differences in the expression of the disease.
Specifically, inheritance of haplotypes associated with low TNF
synthesis is more likely in patients who develop nephritis [38].
A similar phenomenon has also been described in murine lupus
[401 and diabetes in NOD mice [411.
Finally, the influence of HLA specificities on the persistence
of the ANCA response could explain differences between the
present results and those reported previously. We and others
have previously described a high frequency of HLA-DR2 in
small groups of patients with vasculitis [27] or RPGN [281.
Patients with persistent ANCA have a greater chance of relaps-
ing [61 and are more likely to have prolonged follow-up. Cross
sectional studies of patients attending a clinic are likely to
include more such patients, which could introduce an ascertain-
ment bias favoring DR2. Even so, the number of patients in the
earlier studies were small, the HLA typing methods used were
less rigorous, and the patients studied were necessarily less well
characterized.
In conclusion, this study suggests that HLA specificities have
an influence on susceptibility to Wegener's granulomatosis and
microscopic polyarteritis and provides a further insight into its
pathogenesis.
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